US2010222296A1PendingUtilityA1

Pyrimidines, such as uridine, in treatments for patients with bipolar disorder

Assignee: MCLEAN HOSPITAL CORPPriority: Jun 10, 2004Filed: May 12, 2010Published: Sep 2, 2010
Est. expiryJun 10, 2024(expired)· nominal 20-yr term from priority
Inventors:Perry Renshaw
A61P 25/22A61P 25/24A61P 25/00A61K 31/70A61P 25/18
44
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

The invention is based on the discovery that specific dosages of pyrimidine compositions, such as uridine compositions, can be used to treat patients diagnosed with bipolar disorder.

Claims

exact text as granted — not AI-modified
1 . A method of treating an individual exhibiting one or more symptoms of bipolar disorder, the method comprising administering to the individual an effective amount of a uridine composition. 
     
     
         2 . A uridine composition for use in treating an individual exhibiting one or more symptoms of bipolar disorder. 
     
     
         3 . The use of a uridine composition in the manufacture of a medicament for treating an individual exhibiting one or more symptoms of bipolar disorder. 
     
     
         4 . A uridine composition for use in reducing anxiety in an individual suffering from bipolar disorder. 
     
     
         5 . The use of a uridine composition in the manufacture of a medicament for reducing anxiety in an individual suffering from bipolar disorder. 
     
     
         6 . A uridine composition for use in reducing the severity of manic symptoms in an individual in need of treatment for bipolar disorder. 
     
     
         7 . The use of a cytidine composition for the manufacture of a medicament for reducing the severity of manic symptoms in an individual in need of treatment for bipolar disorder.

Join the waitlist — get patent alerts

Track US2010222296A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.